Skip to main content
Premium Trial:

Request an Annual Quote

DNA Testing for Illegal Ivory Trade

The Convention on International Trade in Endangered Species of Wild Fauna and Flora, or CITES, has increased trade regulations for endangered species like sharks, and it has also acknowledged the role that DNA testing could play in tracing illegal ivory to its source, Nature reports. The conference of the parties, or COP, said that such testing should be required when large seizures are made. Phys.org notes that poaching of the African elephant is at its highest level since the ivory trade was banned in 1989. The CITES resolution says that any country that seizes 500 kilograms (about 1100 pounds) or more of ivory must take samples and test them within 90 days, Phys.org adds.

"I was ecstatic because it was the first time that the entire COP acknowledged the value and need for DNA testing for the origin of poached ivory. All my hard work had finally paid off," Samuel Wasser from the University of Washington and who directs the Center for Conservation Biology tells Nature.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.